Table 1 List of important risks linked to romosozumab therapy
List of risks | Risk |
|---|---|
Important identified patient’s risks | Serious cardiovascular disorders such as myocardial infarction and stroke |
Hypocalcemia | |
Hypersensitivity | |
Immunogenicity (development of antibodies to romosozumab) | |
Important identified treatment risks | Osteonecrosis of the jaw |
Atypical femoral fracture | |
Serious infections | |
Post-treatment bone mineral density changes | Osteoporosis rebound effect |